Mochida Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mochida Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Kaken Pharmaceutical Co Ltd
sales of 109.73 billion Japanese Yen [US$985.38 million]
of which 98%
Nippon Shinyaku Co Ltd
(84.21 billion Japanese Yen [US$756.20 million]
of which 84%
was Pharmaceutical Products), and
Towa Pharmaceutical Company Limited
(82.12 billion Japanese Yen [US$737.39 million]
of which 100%
was Pharmaceutical Business).
Mochida Pharmaceutical Company Limited reported sales of ¥92.27 billion (US$828.60 million)
March of 2016.
increase of 5.8%
versus 2015, when the company's sales were ¥87.25 billion.
Despite this increase, sales are still
below the level achieved in 2014, when Mochida Pharmaceutical Company Limited
reported sales of ¥93.95 billion.